Emtricitabin/tenofovirdizoproksil Mylan
The medicinal product has been authorised by the European Commission (EC) via centralised procedure in all EU Member States, based on the European Medicines Agency (EMA) experts' opinion.
| Name | Emtricitabin/tenofovirdizoproksil Mylan |
|---|---|
| Active Substance | emtricitabin tenofovirdizoproksilmaleat |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ograničeni recept |
| Distribution | Supply through pharmacies (community) |
| ATC Code | J05AR03 |
| Marketing status | stavljeno u promet |
| Shortage status | nema nestašice |
| Summary of product characteristics (SmPC), labelling and package leaflet (PL) | download |
| Link to the European Medicines Agency's (EMA) product information | download |
| Link to the European Commission's (EC) decisions | download |
| Educational materials for healthcare professionals |
Lista provjere za propisivača, verzija 2 Edukacijska brošura za propisivače PrEP indikacija, verzija 3 HIV brošura za liječenje pedijatrijskih bolesnika za propisivače, verzija 4 |
| Educational materials for patients / caregivers |
Edukacijska brošura za bolesnike, verzija 2 Kartica za korisnika lijeka, verzija 2 |
